Submit Content
Get the latest delivered to your inbox
Privacy Policy

Alkermes

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

    Substance Use Disorders Impacted 8.3% of American Adults in 2020 Image

    POSTED 

    06-02-22

    Substance Use Disorders Impacted 8.3% of American Adults in 2020

    The 2020 National Survey on Drug Use and Health reports that 8.3% of American adults, or 20.9 million people, in the United States had a substance use disorder in 2020.
     Alkermes Awarded 2022 Platinum Bell Seal for Workplace Mental Health Image

    POSTED 

    05-20-22

    Alkermes Awarded 2022 Platinum Bell Seal for Workplace Mental Health

    We’re proud to announce that we’ve received the 2022 #BellSealforWorkplaceMentalHealth at Platinum from Mental Health America!
    Tips to Improve Mental Well-Being Image

    POSTED 

    05-18-22

    Tips to Improve Mental Well-Being

    It is estimated that up to one-third of cancer patients in hospitals experience negative mental health effects.
    Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month Image

    POSTED 

    05-09-22

    Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month

    May is Mental Health Awareness Month, and it's an important reminder of the tremendous unmet need that still exists for people living with mental health conditions.
    Alcohol-related Deaths Increased by 25% in 2020 Image

    POSTED 

    05-02-22

    Alcohol-related Deaths Increased by 25% in 2020

    A new study from the National Institute on Alcohol Abuse and Alcoholism shows alcohol-related deaths increased by 25% in 2020 and remained elevated in 2021.
    Alkermes Recognizes Minority Cancer Awareness Month Image

    POSTED 

    04-28-22

    Alkermes Recognizes Minority Cancer Awareness Month

    While the industry has made great strides in cancer research and treatments, minority groups in the U.S. continue to bear a greater burden of cancers compared with others.
    LGBTQ+ People Are More Likely to Experience a Mental Health Condition Image

    POSTED 

    04-28-22

    LGBTQ+ People Are More Likely to Experience a Mental Health Condition

    Minority Health Month fact: Lesbian, gay, bisexual, and transgender adults are more likely to experience a mental health condition than cisgender, heterosexual adults.
    Alkermes Encourages You To Learn More About Alcohol Use Disorder Image

    POSTED 

    04-26-22

    Alkermes Encourages You To Learn More About Alcohol Use Disorder

    Alcohol use disorder is a debilitating disease that impacts millions of people every day, and the stigma that surrounds it prevents people from seeking help.
    Alkermes Reflects During National Minority Mental Health Month Image

    POSTED 

    04-22-22

    Alkermes Reflects During National Minority Mental Health Month

    April marks National Minority Health Month, a time for us to reflect on the work still needed to address and break down existing barriers that keep minority communities from seeking mental health care.
    Alkermes Head of Medical Affairs Highlights the Importance of Patient-Focused Drug Development Image

    POSTED 

    04-20-22

    Alkermes Head of Medical Affairs Highlights the Importance of Patient-Focused Drug Development

    In a recent article for Boston Business Journal, Dr. Kanchan Relwani highlights the importance of patient-focused drug development and how we seek to incorporate the patient voice into all we do.
    Alkermes logo

    Alkermes

    Alkermes

    Join today and get the latest delivered to your inbox